This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Obstruction of left anterior descending artery (LAD) due to the thrombosis or atherosclerotic plaques is the leading cause of death worldwide. Targeted delivery of drugs through micro- and nanoparticles is a very promising approach for developing new strategies in clot-busting or treating restenosis. In this work, we modelled the blood flow characteristics in a patient-specific reconstructed LAD artery by the fluid-solid interaction method and based on physiological boundary conditions. Next, we provided a Lagrangian description of micro- and nanoparticles dynamics in the blood flow considering their Brownian motion and the particle-particle interactions. Our results state that the number of spherical particles migrating towards the region of lumen with potential of thrombus existence (PTE) rises by increasing the particle size. Also, an optimum scope of particle size in which the adhesive probability parameter reaches its maximum was determined. We acquired an optimum scope for a specific degree of particle sphericity in which the thrombus surfaces experience the maximum density of interaction with particles. We learned that the ligand-receptor mechanism-based drug carriers are better choices for treating LAD arterial diseases when the addressees are patients with low haematocrit-related diseases. While due to the amount of shear stress exerting on the diseased area, generally exploiting nanoshear-activated drug carriers would be the more effective option when it comes to the thrombolytic therapies of patients with high haematocrit-related diseases.
Coronary artery disease (CAD) is
the prevalent reason of mortality
all around the world. Targeting CAD, specifically atherosclerosis,
with controlled delivery of micro and nanoparticles, as drug carriers,
is a very proficient approach. In this work, a patient-specific and
realistic model of an atherosclerotic plaque in the left anterior
descending (LAD) artery was created by image-processing of CT-scan
images and implementing a finite-element mesh. Next, a fluid–solid
interaction simulation considering the physiological boundary conditions
was conducted. By considering the simulated force fields and particle–particle
interactions, the correlation between injected particles at each cardiac
cycle and the surface density of adhered particles over the atherosclerotic
plaque (SDP) were examined. For large particles (800 and 1000 nm)
the amount of SDP on the plaque increased significantly when the number
of the injected particles became higher. However, by increasing the
number of the injected particles, for the larger particles (800 and
1000 nm) the increase in SDP was about 50% greater than that of the
smaller ones (400 and 600 nm). Furthermore, for constant number of
particles, depending on their size, different trends in SDP were observed.
Subsequently, the distribution and adhesion of metal-based nanoparticles
including SiO2, Fe3O4, NiO2, silver and gold with different properties were simulated. The injection
of metal particles with medium density among the considered particles
resulted in the highest SDP. Remarkably, the affinity, the geometrical
features, and the biophysical factors involved in the adhesion outweighed
the effect of difference in the density of particles on the SDP. Finally,
the consideration of the lift force in the simulations significantly
reduced the SDP and consistently decreased the particle residence
time in the studied domain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.